CNN Money Top Stories

Read full story for latest details.

Read full story for latest details.

Canada's top pharmacy chain -- Shoppers Drug Mart -- is hoping to be the first to legally sell over-the-counter medical marijuana.

Obama administration defends Obamacare in face of 22% jump in premiums next year.

Read full story for latest details.

A visibly angry Newt Gingrich, speaking as a surrogate for Donald Trump, battled Megyn Kelly in a TV segment that left Trump supporters accusing Kelly of bias.

A new analysis of ExxonMobil's finances released on Wednesday highlights the stress the oil giant is under due to low oil prices and mounting debt.

Read full story for latest details.

Housing is having a solid year. But is it about to dip again? Prices may now be so high that buying isn't affordable for many. And companies like Whirlpool and Sherwin-Williams have reported weak results. That could be a troubling sign.

Gucci has got its groove back. Investors are just realizing this and bidding up shares in parent company, Kering.

Southwest Airlines stock plunges after airline reports lower than expected fares through this year's holiday travel period.

Food shortages, recession, skyrocketing inflation and a plummeting currency are just a few issues causing Venezuela to dive deeper into crisis.

Read full story for latest details.

Starting a new business in New Zealand takes less than one day. In Venezuela, it takes 230.

Japanese automaker Toyota says it's recalling another 5.8 million vehicles around the world because of faulty Takata airbags.

It's the elephant in the room that Wall Street Journal reporters couldn't help but ask about: The AT&T and Time Warner deal.

President Obama says the U.S. doesn't know who carried out the massive cyberattack that crippled the internet last week, but one top federal official said "preliminary" evidence indicated it was not done by a government.

The internet is defenseless against another massive cyberattack.

A partner at Draper Fisher Jurvetson, the first firm to put in money into the company helmed by Elizabeth Holmes, thinks that the press' attention to Theranos has been overkill.